To be Canadian is to be the best version of ourselves, for each other and for others. Foundational to this vision is the ability to enjoy good health and wellbeing. This is the purpose that makes us who we are – a fast growing Canadian cannabis company that provides innovative, superior, cost-effective cannabis solutions.
TerrAscend is a Canadian owned, operated, and publicly traded cannabis company.
We are a vertically integrated Cannabis company with quality products and services that meet the evolving needs of our clients. We are strategically located in Mississauga’s Life Sciences hub – a great city that is leading today for tomorrow.
Terra: Earth, land
Ascend: to climb, to rise to a higher point, rank
Our Aboriginal communities believe the hummingbird teaches us to appreciate and love the miracle of being alive. It is often portrayed as a healer or spirit being that helps people in need. It is said that if a hummingbird appears during a time of great sorrow and pain, it means healing is sure to follow.
Even as we ascend new heights to heal, we stay grounded in our core values of innovation and quality.
Our team is comprised of bright, dedicated and experienced professionals that have a demonstrated reputation for quality and creating value.
Basem Hanna is the President and Chief Executive Officer of TerrAscend.
Basem has deep expertise in finance, real estate and corporate operations and founded the real estate fund Almega Capital Limited Partnership in 2011. Almega currently has a assets valued at over $30 million across Ontario.
Basem has a B.A. (Hons.) in Business Administration from the Richard Ivey School of Business at Western University.
Michael Nashat is the Chief Operating Officer of TerrAscend.
Michael is the former Executive Director of the OnPharm Independent Pharmacy Group, which represents the commercial interests of over 340 pharmacies with annual sales of over $300 million.
Michael is a former board member with the Ontario College of Pharmacists, Canadian Foundation for Pharmacy, and the Canadian Association of Chain Drug Stores. He is also a former member of the Ontario Ministry of Health and Long Term Care’s Pharmacy Council, and currently serves as the Co-chair of the Ontario Pharmacists Association’s Owners Advisory Council.
Michael has a Pharm.D. from the Albany College of Pharmacy and Health Science, and completed his Post-Doctoral Fellowship in Neuroscience Medical Strategy at Bristol Myers Squibb/Rutgers University in New Jersey, U.S.
Vijay Sappani is the Chief Strategy Officer of TerrAscend.
Vijay held senior positions with Natco Pharma (Canada) Inc. and Biovail. He also served as Senior Special Assistant to the Ontario Minister of Health and Long Term Care and was a member of the board for the ministry’s Pharmacy Council as well as the Katz Group’s advisory council for self-distribution. Additionally, Vijay has served on the boards of several organizations and is an active community volunteer.
Vijay has a B. Pharm. from the Tamil Nadu Dr. MGR Medical University in Chennai, India and a post-graduate diploma in Marketing Management from the Business School at Humber College.
Dr. Gopal Bhatnagar is a Director of TerrAscend.
Gopal is the Head of the Cardiovascular Surgery Unit at the Trillium Health Centre and was the former Chief of Staff at the Centre. He is also an Assistant Professor of Surgery at the University of Toronto.
Gopal is the co-founder of one of the largest e-cigarette suppliers and retailers in Canada. He also previously served on the Canadian Forces as part of the medical corps and on the Canadian Armed Reserve Forces.
Gopal received his M.D. from the University of Western Ontario.
Richard Mavrinac is a Director of TerrAscend.
Richard has served as the Chief Financial Officer of George Weston Limited and Executive Vice President of Loblaw Companies Limited.
Richard began his career with Loblaw Companies Limited holding a variety of senior financial positions including Senior Vice President, Finance for George Weston Limited and Loblaw Companies Limited.
Richard has a B.Com. from the University of Toronto and is a Chartered Professional Accountant.
We have five emerging ventures that embody our values of innovation and superior quality.
Solace Health is a research and development medical cannabis company that is licensed to cultivate cannabis under Health Canada's Access to Cannabis for Medical Purposes Regulations (ACMPR).
Solace Heath’s 67,300 square foot production facility encompasses the highest level of security and adheres to strict environmental and research practices.
Solace Health’s industry-leading healthcare professionals and expert production staff collaborate with key stakeholders, healthcare professionals, and patients to develop superior medical cannabis that is safe, efficacious and exceeds the highest regulatory standards to improve patient quality of life.
Terra Health Network is a provider of clinical support and education programs led by health care professionals.Terra Health Network strives to empower patients to achieve optimal well-being, living happier and healthier lives.
Terra Health Network is committed to providing state of the medical cannabis solutions for Canadians suffering from chronic pain and debilitating illnesses.
We are also working on:
TerrAscend closes $52,500,000 private placement financing
December 11th, 2017
TerrAscend announces Q3 2017 financials
November 30th, 2017
TerrAscend announces transformative $52,500,000 private placement financing
November 15th, 2017
TerrAscend Announces Appointment of Interim Chief Financial Officer
November 11th, 2017
TerrAscend Provides Update on Convertible Debenture.
September 19th, 2017
TerrAscend Commences Cultivation of Medical Cannabis.
August 29th, 2017
TerrAscend Closes Second Tranche of its Private Placement.
August 16th, 2017
TerrAscend Closes First Tranche of its Private Placement.
July 31st, 2017
TerrAscend Launches Terra Health Network
May 16, 2017
CONTACT INVESTOR RELATIONS
We’re growing fast and looking for top talent to join our team. Click on a link below to submit your application.
Medical Sales Representative
The Key Account Manager’s primary responsibilities entail developing and executing sales strategies of the organization, and leveraging the marketing assets to build and support our growing patient base.
October 26th, 2017